MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-23-0067175
Aureole Pharma Private Limited
Aureole Pharma Private Limited - agriculture in Sinnar, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.11 Cr
▲ 35% YoY
Net profit · FY 2025
₹18.51 Lakh
Net margin 1.5%
EBITDA · FY 2025
₹66.64 Lakh
EBITDA margin 5.5%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹30 Lakh
Issued & subscribed
Open charges
₹4.8 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Employees · EPFO
47
Provident fund records
About Aureole Pharma Private Limited
Data last updated:
Aureole Pharma Private Limited is a private limited company based in Sinnar, Maharashtra, India. It operates in the animal feeds segment of the agriculture sector. It was incorporated on 18 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC366012.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹30 Lakh. It is led by directors Sapna Kiran Badgujar and Kiran Chhagan Badgujar.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.B – 61 Malegaon MIDC Taluka – Sinnar, Nashik, Maharashtra, India – 422113.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.11 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹18.51 Lakh (net margin 1.5%) and EBITDA of ₹66.64 Lakh (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years.
The company has about 47 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.8 Cr on record.
Aureole Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-23-0067175).
Company details
CIN U24290MH2021PTC366012
Registration Number 366012
Incorporation Date 18 August 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-MH-23-0067175
Recognitions & Rankings of Aureole Pharma
Contact details
Aureole Pharma Private Limited's registered office is in Sinnar, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.B – 61 Malegaon MIDC Taluka – Sinnar, Nashik, Maharashtra, India – 422113
- IndustryAgriculture, Animal Feeds
To see the full contact details of Aureole Pharma Private Limited, buy the company report.
Comprehensive company report
Aureole Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aureole Pharma is manufacturing. In detail, this covers electrical equipment, general purpose and special purpose machinery & equipment, transport equipment.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C10 | Electrical equipment, General Purpose and Special purpose Machinery & equipment, Transport equipment |
To see the full business activity and turnover split of Aureole Pharma Private Limited, buy the company report.
Financials of Aureole Pharma Private Limited
FY 2025 filings availableAureole Pharma Private Limited reported revenue of ₹12.11 Cr (up 35% YoY) for FY 2025.
Revenue · FY 2025
₹12.11 Cr ▲ 35%
Net profit · FY 2025
₹18.51 Lakh margin 1.5%
EBITDA · FY 2025
₹66.64 Lakh margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 35%
3 years · compounded
▲ 62%
EBITDA CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 67%
Revenue has grown at a compounded annual rate (CAGR) of 62% over three years, including 35% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹66.64 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹18.51 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.5% | |||
| Net Profit Margin | 1.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Aureole Pharma Private Limited, buy the company report.
Board of directors of Aureole Pharma Private Limited
Aureole Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sapna Kiran Badgujar Also directs: Auraazion Lifesciences LLP, Aureole Process Equipments Private Limited, Mack Auraa Healthcare Private Limited and 1 more | Director | 18 Aug 2021 | 5 Years 2 Months | Current |
| Kiran Chhagan Badgujar Also directs: Auraazion Lifesciences LLP, Aureole Process Equipments Private Limited, Mackea Protech Private Limited and 2 more | Director | 01 Sep 2023 | 3 Years 1 Months | Current |
Peer comparison
Aureole Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Machinery and Equipment industry (Animal Feeds, Industrial Products Manufacturers), with the same principal business activity (electrical equipment, general purpose and special purpose machinery & equipment, transport equipment), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Banco New Energy Cooling Systems Limited | ₹12.12 Cr (FY 2025) | 126.0% | Vadodara, Gujarat, India | |||
| Aureole Pharma Private Limitedthis company | ₹12.11 Cr (FY 2025) | ₹18.51 Lakh | 1.5% | 35.0% | Sinnar, Maharashtra, India | |
| Wecome Tradelink Private Limited | ₹12.08 Cr (FY 2024) | Ahmedabad, Gujarat, India | ||||
| Sri Shakti Gravures India Private Limited | ₹12.08 Cr (FY 2024) | -3.0% | Bengaluru, Karnataka, India |
To see the full peer comparison of Aureole Pharma Private Limited, buy the company report.
Auditor
Aureole Pharma Private Limited is audited by SDP & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SDP & Co. | FY 2022 | 119106W |
Shareholding
The shareholding of Aureole Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Aureole Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹4.8 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Mar 2025 | 101073130 | Idbi Bank Limited | ₹2 Cr | Open | |
| 12 Nov 2024 | 101055309 | Idbi Bank Limited | ₹1.8 Cr | Open | |
| 16 Apr 2024 | 100913142 | Idbi Bank Limited | ₹1 Cr | Open |
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Aureole Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aureole Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aureole Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aureole Pharma Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Shubham Kiran Badgujar ceased to be Director on 08 Sep 2023.
AGM
Aureole Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Aureole Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Idbi Bank Limited amounted to Rs. 200.00 Lakh with Charge ID 101073130 was registered on 18 Mar 2025.
Charges
A charge with Idbi Bank Limited amounted to Rs. 180.00 Lakh with Charge ID 101055309 was registered on 12 Nov 2024.
Charges
A charge with Idbi Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 100913142 was registered on 16 Apr 2024.
Ceased
Shubham Kiran Badgujar ceased to be Director.
Appointed
Kiran Chhagan Badgujar was appointed as Director.
Appointed
Sapna Kiran Badgujar was appointed as Director.
Appointed
Shubham Kiran Badgujar was appointed as Director.
Incorporation
18 Aug 2021
Aureole Pharma Private Limited was registered on 18 Aug 2021 with Roc Mumbai Ii & aged 5 years 2 months as per MCA records.
Frequently asked questions
Aureole Pharma is an active private limited company based in Sinnar, Maharashtra, India. The company works in animal feeds, within the agriculture industry. It was incorporated on 18 August 2021 (5+ years old) and is registered under CIN U24290MH2021PTC366012.
Aureole Pharma has 2 current directors:
- Sapna Kiran Badgujar - Director
- Kiran Chhagan Badgujar - Director
The latest financial statements of Aureole Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Aureole Pharma is U24290MH2021PTC366012. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aureole Pharma was incorporated on 18 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aureole Pharma by revenue are Banco New Energy Cooling Systems Limited, Wecome Tradelink Private Limited, Sri Shakti Gravures India Private Limited, all in the Machinery and Equipment industry (Animal Feeds, Industrial Products Manufacturers), with the same principal business activity (electrical equipment, general purpose and special purpose machinery & equipment, transport equipment).
Shubham Kiran Badgujar ceased to be Director on 08 Sep 2023. Kiran Chhagan Badgujar was appointed as Director on 01 Sep 2023. Sapna Kiran Badgujar was appointed as Director on 18 Aug 2021. Aureole Pharma has 4 board changes on record in total.
Yes, Aureole Pharma is registered as an MSME under Udyam registration (number: UDYAM-MH-23-0067175).
The registered office of Aureole Pharma is at Plot No.B – 61 Malegaon MIDC Taluka – Sinnar, Nashik, Maharashtra, India – 422113.
Aureole Pharma operates in the agriculture industry, in the animal feeds segment.
Aureole Pharma has open charges of ₹4.8 Cr and no satisfied charges on record as per latest MCA filings.